Recent developments in radiotracers targeting tumour stromal and surface markers, such as fibroblast activation protein (FAP) and Nectin‐4, have further expanded the application of immuno‐PET/CT beyond traditional markers, demonstrating excellent tumour visualization and potential utility for patient stratification.42, 43, 44, 45. This evidence concerns the gene FAP and neoplasm.